Spine and sacroiliac joint involvement in newly diagnosed inflammatory bowel disease patients – clinical and magnetic resonance imaging findings from a population-based cohort
Nora Vladimirova,Jakob Møller,Mohamed Attauabi,Gorm Madsen,Jakob Seidelin,Lene Terslev,Kasper Kjærulf Gosvig,Hartwig Roman Siebner,Sanja Bay Hansen,Viktoria Fana,Charlotte Wiell,Flemming Bendtsen,Johan Burisch,Mikkel Østergaard
DOI: https://doi.org/10.14309/ajg.0000000000003039
2024-08-27
The American Journal of Gastroenterology
Abstract:Background: In IBD patients, co-occurring spondyloarthritis (SpA) leads to poorer outcomes and impaired quality of life, highlighting the importance of early detection and effective treatment. This is the first study to assess the prevalence and distribution of axial symptoms and MRI-detected involvement of the spine and sacroiliac joints (SIJs) in early IBD. Methods: Newly diagnosed IBD patients from a prospective, population-based cohort were consecutively recruited. Rheumatological interview, clinical, ultrasound and MRI assessment for SIJ and spine inflammatory and structural lesions were made using validated scoring methods and consensus definitions of axial (ax)SpA. Results: Of 110 patients (ulcerative colitis: 70, Crohn's disease: 40, mean age 42 years, 40% male), 48 (44.9%) reported back and/or buttock pain and 10 (9.1%) had inflammatory back pain. Seventeen (16.7%) patients had MRI findings indicative of axSpA; only 10 of these patients had axial symptoms. Inflammatory MRI lesions were present in SIJs and the spine of 27 (26.5%) and 30 (30.3%) patients, respectively. The ASAS classification criteria for axSpA were met in 11 (10%) cases. MRI findings typical of axSpA were associated with peripheral joint and entheseal inflammation detected by ultrasound (p=0.04). No differences in clinical or imaging findings were found between UC and CD patients. Conclusion: One-in-six newly diagnosed IBD patients had MRI findings indicative of axSpA. As 40% of these patients were asymptomatic, this suggests that axSpA is underdiagnosed in early IBD. Multidisciplinary collaboration is essential to ensure early detection of axial inflammation and to enable optimal therapy preventing future structural damage and disability.
gastroenterology & hepatology